SCHEMBL194201

SCHEMBL194201

CCCCCCCCN1C(=C2SC(=S)N(CC)C2=O)Sc2ccccc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 16/20 0.78
▸ KMT2A Q03164 16/20 0.78
▸ MAPT P10636 8/20 0.74
▸ POLB P06746 6/20 0.74
▸ MMP13 P45452 2/20 0.74
▸ ALOX15 P16050 2/20 0.67
▸ ALOX12 P18054 2/20 0.67
▸ CASP1 P29466 2/20 0.67
▸ CASP7 P55210 2/20 0.67
▸ HSD17B10 Q99714 2/20 0.67
▸ LMNA P02545 2/20 0.67
▸ HPGD P15428 1/20 0.67
▸ SMN1; SMN2 Q16637 3/20 0.65
▸ CTDSP1 Q9GZU7 2/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ ALDH1A1 P00352 5/20 0.52
▸ TDP1 Q9NUW8 4/20 0.52
▸ GFER P55789 1/20 0.52
▸ NPSR1 Q6W5P4 3/20 0.51
▸ GAA P10253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL194200 1.00 MEN1 (0.78) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL30000370 1.00 MEN1 (0.78) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL8887899 0.88 MEN1 (1.00) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL7019338 0.88 MEN1 (1.00) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL10036060 0.88 MEN1 (1.00) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL9858108 0.85 MEN1 (1.00) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL9858105 0.85 MEN1 (1.00) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL2333246 0.83 MEN1 (0.81) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL2333243 0.83 MEN1 (0.81) MEN1KMT2AMAPTPOLBMMP13
SCHEMBL15995453 0.83 MEN1 (0.81) MEN1KMT2AMAPTPOLBMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382868-B2 Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same ICURE PHARMACEUTICAL INC. (KR) 2022-07-12 — — US claimed
US-20190046463-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME ICURE PHARMACEUTICAL INC. (KR) 2019-02-14 — — US claimed
EP-3415141-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME Icure Pharmaceutical Inc. (KR) 2018-12-19 — — EP claimed
EP-4743828-A1 PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING BASF SE (DE) 2026-05-20 — — EP disclosed
US-20250149336-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-05-08 — — US disclosed
WO-2025011754-A1 PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING BASF SE (DE) 2025-01-16 — — WO disclosed
EP-4114825-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2024-11-20 — — EP disclosed
WO-2024181097-A1 PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED ARTICLE, FILM, OPTICAL ELEMENT, IMAGE SENSOR, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-09-06 — — WO disclosed
WO-2024043108-A1 PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED FILM, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR 富士フイルム株式会社 2024-02-29 — — WO disclosed
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 — — US disclosed
EP-4114825-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-01-11 — — EP disclosed
US-20050260520-A1 Heat stable photocurable resin composition for dry film resist CIBA SPECIALTY CHEMICALS CORP. 2005-11-24 — — US disclosed
US-6949678-B2 Oxime ester photoinitiators CIBA SPECIALTY CHEMICALS CORP. (US) 2005-09-27 — — US disclosed
US-20050191567-A1 Oxime ester photoinitiators KUNIMOTO KAZUHIKO (JP) 2005-09-01 — — US disclosed
US-6806024-B1 MIXTURES OF ADDITION POLYMERS AND ACTIVATORS COMPRISING NITROGEN COMPOUNDS, USED AS SUBSTRATE COATINGS FOR COLOR FILTERS CIBA SPECIALTY CHEMICALS CORPORATION 2004-10-19 — — US disclosed
US-20040192804-A1 Photosensitive resin composition IGM GROUP B.V. (NL) 2004-09-30 — — US disclosed
US-20040170924-A1 Oxime ester photoiniators having a combined structure CIBA CORPORATION 2004-09-02 — — US disclosed
US-6596445-B1 Initiators for photopolymerization of radically polymerizable compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-22 — — US disclosed
US-20020020832-A1 Photosensitive resin composition CIBA SPECIALTY CHEMICALS CORP. 2002-02-21 — — US disclosed
US-20010012596-A1 For resist applications; thermostability, storage stability CIBA SPECIALTY CHEMICALS CORP. 2001-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 MEN1 4834/4885KMT2A 3437/4885MAPT 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback